DRKS00012447
Completed
Not Applicable
ongterm follow-up of a controlled randomized trial of single-port laparoscopic cholecystecomy vs. multiport laparoscopic cholecystecomy
Charité Campus Charité Mitte0 sites200 target enrollmentMay 12, 2017
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- K80
- Sponsor
- Charité Campus Charité Mitte
- Enrollment
- 200
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Colecystectomy as primary operation, Patients older than 18 years od Age, Participation of the previous controlled randomized trial comparing the single\-port and multiport laparoscopic cholecystectomy.
Exclusion Criteria
- •Not self\-sufficient patients, patients under 18 years, patient's desire
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
ong term follow up of randomised clinical trial on total joint arthroplasty or trapeziectomie for trapeziometacarpal osteoarthritistrapeziometacarpal osteoarthritiscarpometacarpal osteoarthritis10023213NL-OMON42533Isala Klinieken55
Completed
Not Applicable
A follow-up of the Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women (REVAMP) and their children: REVAMP Extendanaemiairon deficiencychild developmentChild growthMaternal depressionInfectionBlood - AnaemiaPublic Health - Other public healthACTRN12620000382976niversity of Malawi, College of Medicine862
Active, not recruiting
Not Applicable
ong-term follow-up of breast cancer survivors: A randomized controlled studyBreast cancer survivorshipCancerBreast cancerISRCTN15403211Koo Foundation Sun Yat-Sen Cancer Center902
Not yet recruiting
Not Applicable
Mid-term follow-up of a randomized controlled trial comparing ultrasound-guided double percutaneous needling versus high-energy extracorporeal shockwave therapy in the treatment of calcific tendinitis of the rotator cuff.NL-OMON51922Spaarne Gasthuis81
Completed
Phase 3
REGiM: Prolonged treatment with darbepoetin alpha (EPO), with/without recombinant human granulocyte colony stimulating factor (G-CSF), versus best supportive care in patients with low-risk myelodysplastic syndromes (MDS)Topic: National Cancer Research NetworkSubtopic: Haematological OncologyDisease: Leukaemia (acute myeloid)CancerMyelodysplastic syndromesISRCTN65652441Barts and The London NHS Trust (UK)1,200